European Academy of Dermatology and Venereology

Positive Results from 2 Novartis Trials for HS Treatment
September 13, 2022

SUNSHINE and SUNRISE trials showed superior efficacy over the placebo.

A Fresh Look at Alopecia Areata
September 10, 2022

Taking a deep dive into alopecia areata allows for a better understanding of the cells that are responsible for disease development.

Doctor Provides Overview on Assessing Vitiligo at EADV 2022
September 09, 2022

Medical experts use common set of criteria to diagnose disease.

Evidence of Cumulative Life Course Impairment in Hidradenitis Suppurativa
September 09, 2022

Study data was presented at EADV 2022 regarding socioeconomic status related to HS.

Relationship Between BCC and Transplant Patients Analyzed at EADV Congress
September 09, 2022

The relationship between transplant patients and basal cell carcinoma was discussed at EADV Congress 2022 in Milan, Italy.

Timber Pharmaceuticals Presents CI Study Data at EADV Congress
September 08, 2022

TMB-001 showed positive results in the reduction of congenital ichthyosis severity in a phase 2b CONTROL study.

New Study Finds Skin Immune Biomarker Test Helps Predict Eczema in Babies
September 07, 2022

New sticky tape study can help predict onset of pediatric atopic eczema in babies.

Updates on Mental Health and Psoriasis at EADV 2022
September 07, 2022

The relationship between mental health and psoriasis was discussed at EADV Congress 2022 in Milan, Italy.

Arcutis to Present Data Fom Topical Roflumilast Clinical Program at EADV 2022 Congress
September 06, 2022

Arcutis to present data from topical roflumilast clinical program at EADV 2022 Congress.

New Data from AbbVie Will Be Presented at EADV 2022 Congress
August 31, 2022

Abstracts will include updates on treatment for psoriatic arthritis, psoriasis, atopic dermatitis, and more.